Compare Novo Nordisk A/S (NVO) vs Packaging Corporation of America (PKG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Packaging Corporation of America — how do they compare? Novo Nordisk A/S trades at $49.33 (market cap $220.53B), while Packaging Corporation of America trades at $228.04 (market cap $20.77B). The key difference: Novo Nordisk A/S is far larger — about 10.6× Packaging Corporation of America's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.
| NVO | PKG | |
|---|---|---|
Market Cap | $220.53B | $20.77B |
Sector | Health | Technology |
52-Week High | $71.70 | $246.31 |
52-Week Low | $35.29 | $191.41 |
Enterprise Value | $239.49B | $24.59B |
Dividend Yield | 3.63% | 2.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →
